摘要
在过去的九年,我们中心已经发展成为中国最大的葡萄膜炎转诊中心。来处理这个增加的病人,我们已经开发出一种与我们的病人管理系统协调沟通,他们所指的眼科医生,咨询与其他医学专业和worldrenowned外国葡萄膜炎专家。我们建立了葡萄膜炎患者的最大数据库记录允许连续临床特征分析和对治疗的反应的各种葡萄膜炎患者实体以及评价各种辅助测试的相关性表现在这个病人组。建立一个生物标本已被证明是在研究这种疾病的免疫病理机制复杂。病人护理和临床研究之间的密切互动一个屋檐下导致了小说的理解疾病机制,无疑将导致一个量身定制的治疗这种疾病。
关键词: 葡萄膜炎、炎症、失明、标本生物、免疫病理机制
Current Molecular Medicine
Title:How To Deal With Uveitis Patients?
Volume: 17 Issue: 7
关键词: 葡萄膜炎、炎症、失明、标本生物、免疫病理机制
摘要: During the past nine years, our center has grown into the largest uveitis referral center in China. To deal with this increasing stream of patients we have developed a management system to coordinate communication with our patients, their referring ophthalmologists, consultations with other medical specialties and worldrenowned foreign uveitis specialists. We have established the biggest database of uveitis patients records allowing continuous analysis of clinical features and response to treatment of patients with various uveitis entities as well as the evaluation of the relevance of various ancillary tests performed in this patient group. The establishment of a specimen biobank has been shown to be instrumental in the research on the complex immunopathological mechanisms involved in this disease. The close interaction between patient care and clinical research under one roof has led to a novel understanding of disease mechanisms and will undoubtedly lead to a tailored treatment for this disease.
Export Options
About this article
Cite this article as:
How To Deal With Uveitis Patients?, Current Molecular Medicine 2017; 17 (7) . https://dx.doi.org/10.2174/1566524018666180207153342
DOI https://dx.doi.org/10.2174/1566524018666180207153342 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers